CF
IART icon

Corebridge Financial’s Integra LifeSciences IART Stock Holding History

Corebridge Financial’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,283
Closed -$776K – 1282
2025
Q1 		$776K Sell
35,283
-689
-2% -$16.2K ﹤0.01% 1381
2024
Q4 		$816K Sell
35,972
-2,821
-7% -$61.6K ﹤0.01% 1424
2024
Q3 		$705K Sell
38,793
-963
-2% -$22.3K ﹤0.01% 1547
2024
Q2 		$1.16M Buy
+39,756
New +$1.18M 0.01% 1257

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Corebridge Financial's IART Position: Q2 2025 in Review

Corebridge Financial sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 35,283 shares — an estimated $776K sold.

Corebridge Financial first reported a position in IART in Q2 2024 and held it in 4 quarters. The position peaked at $1.16M in Q2 2024. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

  • Corebridge Financial reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 35,283 Integra LifeSciences shares in Q2 2025, an estimated $776K.
  • Corebridge Financial first reported a position in Integra LifeSciences in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Integra LifeSciences position peaked at $1.16M in Q2 2024.
  • 208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.